Global Hospital-Acquired Infection (HAI) Diagnostic Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Hospital-Acquired Infection (HAI) Diagnostic market size will reach US$ million by 2031.
A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI).
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LPI (LP Information)' newest research report, the “Hospital-Acquired Infection (HAI) Diagnostic Industry Forecast” looks at past sales and reviews total world Hospital-Acquired Infection (HAI) Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Hospital-Acquired Infection (HAI) Diagnostic sales for 2025 through 2031. With Hospital-Acquired Infection (HAI) Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hospital-Acquired Infection (HAI) Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Hospital-Acquired Infection (HAI) Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hospital-Acquired Infection (HAI) Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hospital-Acquired Infection (HAI) Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hospital-Acquired Infection (HAI) Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hospital-Acquired Infection (HAI) Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infection (HAI) Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Molecular Diagnostics
Blood Tests
Urinalysis
Segmentation by Application:
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
bioMérieux
Abbott Laboratories
Alere, Inc.
Roche
Siemens Healthcare
Becton Dickenson
Cepheid Inc.
Thermo Fisher Scientific
Seegene, Inc.
Qiagen
Please note: The report will take approximately 2 business days to prepare and deliver.
A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI).
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LPI (LP Information)' newest research report, the “Hospital-Acquired Infection (HAI) Diagnostic Industry Forecast” looks at past sales and reviews total world Hospital-Acquired Infection (HAI) Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Hospital-Acquired Infection (HAI) Diagnostic sales for 2025 through 2031. With Hospital-Acquired Infection (HAI) Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hospital-Acquired Infection (HAI) Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Hospital-Acquired Infection (HAI) Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hospital-Acquired Infection (HAI) Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hospital-Acquired Infection (HAI) Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hospital-Acquired Infection (HAI) Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hospital-Acquired Infection (HAI) Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infection (HAI) Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Molecular Diagnostics
Blood Tests
Urinalysis
Segmentation by Application:
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
bioMérieux
Abbott Laboratories
Alere, Inc.
Roche
Siemens Healthcare
Becton Dickenson
Cepheid Inc.
Thermo Fisher Scientific
Seegene, Inc.
Qiagen
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
93 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Player
- 4 Hospital-Acquired Infection (HAI) Diagnostic by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Hospital-Acquired Infection (HAI) Diagnostic Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
